https://mc06.manuscriptcentral.com/cjpp-pubs Canadian Journal of Physiology and Pharmacology D r a f t ABSTRACT Brain glucose uptake declines during aging and is significantly impaired in Alzheimer's disease. Ketones are the main alternative brain fuel to glucose so they represent a potential approach to compensate for the brain glucose reduction. Caffeine is of interest as a potential ketogenic agent owing to its actions on lipolysis/ lipid oxidation but whether it is ketogenic in humans is unknown. This study aimed to evaluate the acute ketogenic effect of two doses of caffeine in healthy adults (2.5; 5.0 mg/kg) during a 4-hour metabolic study period. Caffeine given at breakfast significantly stimulated ketone production in a dosedependent manner (+88%; +116%) and also raised plasma free fatty acids. Whether caffeine has longterm ketogenic effects or could enhance the ketogenic effect of medium chain triglycerides remains to be determined.
Caffeine upregulates metabolic rate (Miller et al. 1974) , and stimulates energy expenditure. It is an 3 adenosine receptor antagonist that increases sympathetic activity (Bellet et al. 1969 ) and inhibits cyclic 4 nucleotide phosphodiesterase, which is responsible for catalyzing the conversion of cyclic adenosine 5 monophosphate (cAMP) to AMP (Butcher et al. 1968; Quan et al. 2013) . As a result, higher tissue 6 concentrations of cAMP activate hormone-sensitive lipase and promote lipolysis (Acheson et al. 2004;  7 Butcher et al. 1968) . Free fatty acids (FFA) are the product of lipolysis and can be used as an immediate 8 source of energy by many organs. They can also be converted by the liver into ketones (acetoacetate
9
[AcAc], β-hydroxybutyrate [β-HB] and acetone). Most organs use glucose and FFA as energy substrates.
10
However, the brain is unable to use FFA for energy, and requires ketones as the principal alternative fuel 11 to glucose (Cunnane et al. 2016) . Plasma ketones are highly positively correlated to their utilization by the 12 brain (Cunnane et al. 2016; Mitchell et al. 1995) and can provide up to 70% of brain's total energy during 13 period of hypoglycaemia as, for example, during fasting (Owen et al. 1967 ).
15
Brain glucose uptake is 10-15% lower during normal aging (Nugent et al. 2014) , and can be up to 35% 16 lower in certain brain regions in neurodegenerative diseases such as Alzheimer's disease (AD) 17 (Castellano et al. 2015) . Several studies suggest that brain glucose hypometabolism potentially 18 contributes to the onset and/or progression of AD (Cunnane et al. 2016; Mosconi et al. 2005; Nugent et al. 19 2014; Reiman et al. 2004; Schöll et al. 2011) . A ketogenic supplement could therefore potentially help 20 support the brain's energy needs during aging. Hence, the primary aim of this study was to evaluate 21 whether the lipolytic effect of caffeine acutely increases plasma ketones in healthy adults during a four-
22
hour metabolic study period. The secondary aim was to confirm whether caffeine increases FFA as 23 previously reported (Acheson et al. 1980; Acheson et al. 2004 
38

Experimental design
39
The protocol involved three randomized four-hour metabolic study days: a baseline metabolic day (CTL) did not significantly differ from zero on any of the three study days (Fig.1) . There was no difference in 92 plasma glucose, triglycerides, or cholesterol response across the three metabolic days (data not shown).
93
Plasma lactate differed across the three metabolic days (p=0.045), but after normalizing the data to 94 baseline, these differences disappeared (p=0.607).
96
A dose-response was observed for plasma caffeine across the three metabolic days (p<0.05; Fig. 1 ).
97
Plasma caffeine significantly increased during the first hour post-dose (p<0.05). C-2.5 increased plasma
98
caffeine to a maximum of 7.5 ± 1.5 mg/L at 2 h and C-5.0 increased plasma caffeine to a maximum of 99 10.0 ± 2.3 mg/L at 3 h (p<0.05). No difference in plasma AcAc levels was observed across the three test 100 days (p=0.497; Fig 2A, 2C) . However, after normalizing the data to baseline, there was a significant group 101 difference between baseline and the two doses of caffeine at 3.5 h, at which time AcAc was significantly 102 increased (p<0.05; data not shown). A group difference was observed for the β-HB response from 2 to 4 h 103 post-dose (p<0.05; Fig. 2B and 2D ). Caffeine increased plasma β-HB by 88% and 116% in a dose-104 dependent manner (p<0.05). No significant difference in plasma FFA was observed during 0-2 h post-105 dose (Fig. 3A) . Globally, FFA decreased from 711 ± 398 µM to 91 ± 42 µM during this period (Fig. 3A) .
This short-term study showed that caffeine intake can stimulate ketogenesis by increasing β-HB
113
concentrations by 88-116% with a maximum within four hours post-dose. A dose-response was observed
114
for plasma β-HB (Fig. 2D) but not for AcAc (Fig. 2C) , which could be explained by the larger inter-group 115 variation in AcAc. The increase in plasma ketones obtained with these doses of caffeine could at least 116 transiently contribute to 5-6% of brain energy needs (Cunnane et al. 2016) .
117
The increased plasma FFA after caffeine seen in the present study confirms prior results (Acheson et al.
118
1980; Acheson et al. 2004; Bellet et al. 1968; Bellet et al. 1969) . Caffeine competes for the adenosine 119 receptor, inhibits phosphodiesterase activity and increases plasma FFA. FFA entering the liver are beta-
120
oxidized and converted to ketones due to condensation of pairs of acetyl-CoA units as their availability
121
exceeds their utilization by the tricarboxylic acid cycle (Wang et al. 2014) .
123
The increase in blood ketones shown here was equivalent to that observed after an overnight fast.
124
Another way of increasing blood ketones is to provide a source of medium-chain triglyceride ( 
128
One limitation of this study design is that the metabolic study period was only 4 hours. However, this was 129 sufficient to observe an effect on plasma ketones and FFA within the period during which peak plasma 130 caffeine was observed. The half-life of caffeine is 4.5 hours, which suggests that its peak metabolic effect 131 would take place over 2-3 hours. Furthermore, the effect of each caffeine dose was only assessed once, 132 so a longer term study would be useful.
134
In conclusion, by enhancing lipolysis and increasing blood FFA levels, which in turn provide substrates for 
